Insider Selling: Heartflow (NASDAQ:HTFL) Insider Sells $1,657,852.77 in Stock

Heartflow, Inc. (NASDAQ:HTFL) insider Campbell Rogers sold 64,533 shares of the stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an average price of $25.69, for a total value of $1,657,852.77. Following the sale, the insider directly owned 78,518 shares of the company’s stock, valued at approximately $2,017,127.42. The trade was a 45.11% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Campbell Rogers also recently made the following trade(s):

• On Thursday, February 12th, Campbell Rogers sold 65,153 shares of Heartflow stock. The shares were sold at an average price of $24.49, for a total transaction of $1,595,596.97.

Heartflow Stock Down 0.8%

Shares of NASDAQ:HTFL opened at $27.75 on Thursday. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $41.22. The company’s fifty day simple moving average is $26.54 and its 200 day simple moving average is $30.31. The firm has a market cap of $2.38 billion and a price-to-earnings ratio of -13.94.

Wall Street Analyst Weigh In

Several research firms have issued reports on HTFL. Canaccord Genuity Group lifted their price target on Heartflow from $40.00 to $43.00 and gave the company a “buy” rating in a research note on Thursday, March 19th. Weiss Ratings reiterated a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th. JPMorgan Chase & Co. dropped their target price on Heartflow from $40.00 to $35.00 and set an “overweight” rating on the stock in a research report on Thursday, March 19th. Finally, Wells Fargo & Company reduced their price target on Heartflow from $38.00 to $35.00 and set an “overweight” rating for the company in a research report on Thursday, March 19th. Five research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $37.67.

Hedge Funds Weigh In On Heartflow

Large investors have recently modified their holdings of the business. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Heartflow in the fourth quarter valued at about $27,000. TFC Financial Management Inc. acquired a new position in Heartflow during the third quarter valued at approximately $40,000. Russell Investments Group Ltd. bought a new position in Heartflow in the fourth quarter valued at approximately $45,000. Legal & General Group Plc bought a new position in Heartflow in the third quarter valued at approximately $59,000. Finally, Strs Ohio acquired a new position in shares of Heartflow during the 4th quarter worth approximately $99,000.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.